These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2856247)

  • 21. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
    Zong WX; Farrell M; Bash J; Gélinas C
    Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
    Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
    Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
    Nehyba J; Hrdlicková R; Bose HR
    Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suppression of SH3BGRL is important for v-Rel-mediated transformation.
    Majid SM; Liss AS; You M; Bose HR
    Oncogene; 2006 Feb; 25(5):756-68. PubMed ID: 16186799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of transformation by the v-rel oncogene.
    Hannink M; Temin HM
    Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral rel and cellular rel associate with cellular proteins in transformed and normal cells.
    Morrison LE; Kabrun N; Mudri S; Hayman MJ; Enrietto PJ
    Oncogene; 1989 Jun; 4(6):677-83. PubMed ID: 2543940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
    Fan Y; Gélinas C
    Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. v-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity.
    Fujii M; Minamino T; Nomura M; Miyamoto K; Tanaka J; Seiki M
    Leukemia; 1997 Apr; 11 Suppl 3():402-4. PubMed ID: 9209405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transactivation of gene expression by nuclear and cytoplasmic rel proteins.
    Hannink M; Temin HM
    Mol Cell Biol; 1989 Oct; 9(10):4323-36. PubMed ID: 2555689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
    Xu X; Gélinas C
    Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of avian lymphoid cells by reticuloendotheliosis virus.
    Moore BE; Bose HR
    Mutat Res; 1988 Jan; 195(1):79-90. PubMed ID: 2827014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the c-rel and c-myc proto-oncogenes in avian tissues.
    Moore BE; Bose HR
    Oncogene; 1989 Jul; 4(7):845-52. PubMed ID: 2666905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia.
    Metz T; Graf T
    Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation.
    Tong S; Liss AS; You M; Bose HR
    Oncogene; 2007 Apr; 26(16):2318-29. PubMed ID: 17016434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p59v-rel, the transforming protein of reticuloendotheliosis virus, is complexed with at least four other proteins in transformed chicken lymphoid cells.
    Simek S; Rice NR
    J Virol; 1988 Dec; 62(12):4730-6. PubMed ID: 2846883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
    Bechade C; Calothy G
    Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.